Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- SEAGUL2Independent statistical analysis of Study EvAluating Genotypes While Using Lucentis 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01464723).
- SEAIRAIndependent statistical analysis of Studying the Effects of Antihypertensives on Individuals at Risk for Alzheimer's: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SEALIndependent statistical analysis of Use of Tachosil® for Lymph Sealing During Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01920958).
- SEAMLESSIndependent statistical analysis of A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SEARCHIndependent statistical analysis of Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Seborrheic Dermatitis: Ketoconazole 2% Foam Versus Ketoconazole 2% Shampoo: Complete Statistical AnalysisIndependent statistical analysis of Seborrheic Dermatitis: Ketoconazole 2% Foam Versus Ketoconazole 2% Shampoo: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01203189).
- Second Extension Study to Evaluate Safety and Tolerability of Influenza Vaccines in Adults and Elderly, and to Evaluate Immunogenicity and Concomitant Vaccination With Pneumococcal Vaccine in a Subgroup: Complete Statistical AnalysisIndependent statistical analysis of Second Extension Study to Evaluate Safety and Tolerability of Influenza Vaccines in Adults and Elderly, and to Evaluate Immunogenicity and Concomitant Vaccination With Pneumococcal Vaccine in a Subgroup:…
- Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SECOND-LINEIndependent statistical analysis of A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen: primary endpoint results,…
- Second-Line Uterotonics in Postpartum Hemorrhage: A Randomized Clinical Trial: Complete Statistical AnalysisIndependent statistical analysis of Second-Line Uterotonics in Postpartum Hemorrhage: A Randomized Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03584854).
- Secondary HIV Prevention and Adherence Among HIV-infected Drug Users: Complete Statistical AnalysisIndependent statistical analysis of Secondary HIV Prevention and Adherence Among HIV-infected Drug Users: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01741311).
- Secondary Prevention of Osteoporosis: Complete Statistical AnalysisIndependent statistical analysis of Secondary Prevention of Osteoporosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00421343).
- SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil – Fast Admin: Complete Statistical AnalysisIndependent statistical analysis of SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fast Admin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01262989).
- SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil – Fed Admin: Complete Statistical AnalysisIndependent statistical analysis of SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fed Admin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01330303).
- Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma: Complete Statistical AnalysisIndependent statistical analysis of Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00587132).
- Secretin-Stimulated Magnetic Resonance Cholangiopancreatography (S-MRCP) in Pancreatic Patients: Complete Statistical AnalysisIndependent statistical analysis of Secretin-Stimulated Magnetic Resonance Cholangiopancreatography (S-MRCP) in Pancreatic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01094561).
- Secukinumab Safety and Efficacy in Juvenile Psoriatic Arthritis (JPsA) and Enthesitis-related Arthritis (ERA): Complete Statistical AnalysisIndependent statistical analysis of Secukinumab Safety and Efficacy in Juvenile Psoriatic Arthritis (JPsA) and Enthesitis-related Arthritis (ERA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SECUREIndependent statistical analysis of A Post Market Study on the Use of Cormatrix® Cangaroo ECM® (Extracellular Matrix) Envelope: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SED-TUDIndependent statistical analysis of The Effects of Sedatives on Tobacco Use Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03813121).
- Sedentary Behavior Interrupted Randomized Controlled Trial (P2): Complete Statistical AnalysisIndependent statistical analysis of Sedentary Behavior Interrupted Randomized Controlled Trial (P2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03473145).
- SedLine Engineering Data Collection Study in Pediatric Patients Undergoing General Anesthesia or Sedation: Complete Statistical AnalysisIndependent statistical analysis of SedLine Engineering Data Collection Study in Pediatric Patients Undergoing General Anesthesia or Sedation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SEEIndependent statistical analysis of The Support, Educate, Empower (SEE) Program: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04735653).
- SEEDsIndependent statistical analysis of Promoting The Self-Regulation Of Energy Intake: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01513343).
- SEEK: Dissemination and Implementation: Complete Statistical AnalysisIndependent statistical analysis of SEEK: Dissemination and Implementation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03642327).
- SEENIndependent statistical analysis of Sexual and Gender Minority Emerging Adults Eliciting Narratives: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05899218).
- SEERSIndependent statistical analysis of mobiCARE™ ECG Monitoring System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06896734).
- SEGUDIABIndependent statistical analysis of SEGUDIAB Study: Evaluation of Safety in the Diabetic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01087541).
- Seizure Activity in Alzheimer’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Seizure Activity in Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01554683).
- Seizure Detection Using SEDline During Therapeutic Hypothermia in Cardiac Arrest Victims: Complete Statistical AnalysisIndependent statistical analysis of Seizure Detection Using SEDline During Therapeutic Hypothermia in Cardiac Arrest Victims: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Seizure Prophylaxis in Patients With Glioma or Brain Metastasis: Complete Statistical AnalysisIndependent statistical analysis of Seizure Prophylaxis in Patients With Glioma or Brain Metastasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03436433).
- SEJIndependent statistical analysis of Avelumab in Patients With Newly Diagnosed Glioblastoma Multiforme: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03047473).
- SELECTIndependent statistical analysis of Safety and Efficacy Study of Daclizumab High Yield Process (DAC HYP) to Treat Relapsing-Remitting Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- SELECTIndependent statistical analysis of Selinexor in Patients With Advanced Thymic Epithelial Tumor Progressing After Primary Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SELECT-3Independent statistical analysis of Assess Safety & Efficacy of Selumetinib When Given in Combination With Standard First Line Treatment for Advanced Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence…
- SELECT-BEYONDIndependent statistical analysis of A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) With an Inadequate Response or…
- SELECT-EARLYIndependent statistical analysis of A Study to Compare Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have Not Previously Taken Methotrexate: primary endpoint results, effect estimate…
- SELECT2Independent statistical analysis of SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Selecting Insulin Analogs for Closed-Loop Control Using Multiplex Pharmacokinetic Profiling: Complete Statistical AnalysisIndependent statistical analysis of Selecting Insulin Analogs for Closed-Loop Control Using Multiplex Pharmacokinetic Profiling: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01684943).
- Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD: Complete Statistical AnalysisIndependent statistical analysis of Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Myelodysplastic Syndromes: Complete Statistical AnalysisIndependent statistical analysis of Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Myelodysplastic Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Selective Intraoperative Administration of Local Anesthesia in Breast Reconstruction: Complete Statistical AnalysisIndependent statistical analysis of Selective Intraoperative Administration of Local Anesthesia in Breast Reconstruction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02525718).
- SELECTSUNRISEIndependent statistical analysis of A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis (RA) Who Are on a Stable Dose of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) and…
- Selegiline for Smoking Cessation – 1: Complete Statistical AnalysisIndependent statistical analysis of Selegiline for Smoking Cessation - 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00439413).
- Selegiline Patch for Treatment of Nicotine Dependence: Complete Statistical AnalysisIndependent statistical analysis of Selegiline Patch for Treatment of Nicotine Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01330030).
- Selenium and Immune Function: Complete Statistical AnalysisIndependent statistical analysis of Selenium and Immune Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00279812).
- Self Assembling Peptide P11-4 in Patients With Early Occlusal Carious Lesions: Complete Statistical AnalysisIndependent statistical analysis of Self Assembling Peptide P11-4 in Patients With Early Occlusal Carious Lesions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Self Cranial Electrical Stimulation (CES) for Pain in Older Adults With Knee Osteoarthritis (Self CES for Knee Pain): Complete Statistical AnalysisIndependent statistical analysis of Self Cranial Electrical Stimulation (CES) for Pain in Older Adults With Knee Osteoarthritis (Self CES for Knee Pain): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Self-Administered Interactive Exercise Program (Tele-Exergame): Complete Statistical AnalysisIndependent statistical analysis of Self-Administered Interactive Exercise Program (Tele-Exergame): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT07072962).
- Self-administered Lidocaine Gel for Pain-control During Cervical Preparation for Dilation and Evacuation: Complete Statistical AnalysisIndependent statistical analysis of Self-administered Lidocaine Gel for Pain-control During Cervical Preparation for Dilation and Evacuation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain: Complete Statistical AnalysisIndependent statistical analysis of Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…